Burden, access and disparities in kidney disease: chronic kidney disease hotspots and progress one step at a time

Clinical Kidney Journal

Volumn 12, Issue 2, 2018, Pages 157-159

  Ortiz, Alberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

APOL1; Chronic kidney disease hotspot; Hypertensive nephropathy; Malaria; PTH; Vitamin D

Indexed keywords

APOLIPOPROTEIN L1;

ACUTE KIDNEY FAILURE; AFRICAN TRYPANOSOMIASIS; BIBLIOGRAPHIC DATABASE; CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER; CHRONIC KIDNEY FAILURE; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DISEASE ASSOCIATION; DISEASE BURDEN; END STAGE RENAL DISEASE; GENETIC VARIABILITY; HEALTH CARE ACCESS; HEALTH DISPARITY; HIGH INCOME COUNTRY; HIV ASSOCIATED NEPHROPATHY; HUMAN; INCIDENCE; MEDICAL RECORD; PATIENT CARE; PREVALENCE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; RENOVASCULAR HYPERTENSION; REVIEW;

EID: 85068558381     PISSN: 20488505     EISSN: 20488513     Source Type: Journal    
DOI: 10.1093/ckj/sfz026     Document Type: Review

References (17)

1. World Kidney Day. https://www.worldkidneyday.org/2019- campaign/2019-wkd-Theme/(17 February 2019, date last accessed)
2. Crews DC, Bello AK., Saadi G. Burden, access, and disparities in kidney disease. Clin Kidney J 2019 (in this issue)
3. Martín-Cleary C, Ortiz A. CKD hotspots around the world: Where, why and what the lessons are. A CKJ review series. Clin Kidney J 2014; 7: 519-523
4. Abraham G, Varughese S, Thandavan T et al. Chronic kidney disease hotspots in developing countries in South Asia. Clin Kidney J 2016; 9: 135-141
5. Sumaili EK, Shemer R, Kruzel-Davila E et al. G1 is the major APOL1 risk allele for hypertension-attributed nephropathy in Central Africa. Clin Kidney J 2019 (in this issue)
6. Genovese G, Friedman DJ, Ross MD et al. Association of trypanolytic ApoL1 variants with kidney disease in African Americans. Science 2010; 329: 841-845
7. Cavalier E, Yayo ES, Attoungbre-Hauhouot ML et al. Vitamin D, bone alkaline phosphatase and parathyroid hormone in healthy subjects and haemodialysed patients from West Africa: Impact of reference ranges and parathyroid hormone generation assays on the Kidney Disease: Improving Global Outcomes guidelines. Clin Kidney J 2019 (in this issue)
8. Delanaye P, Melsom T, Ebert N et al. Iohexol plasma clearance for measuring glomerular filtration rate in clinical practice and research: A review. Part 2: Why to measure glomerular filtration rate with iohexol? Clin Kidney J 2016; 9: 700-704
9. Levey AS, Stevens LA, Schmid CH et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612
10. Stevens LA, Claybon MA, Schmid CH et al. Evaluation of the Chronic Kidney Disease Epidemiology Collaboration equation for estimating the glomerular filtration rate in multiple ethnicities. Kidney Int 2011; 79: 555-562
11. Adeniyi AB, Laurence CE, Volmink JA et al. Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa. Clin Kidney J 2017; 10: 363-369
12. Moodley N, Hariparshad S, Peer F et al. Evaluation of the CKD-EPI creatinine based glomerular filtration rate estimating equation in Black African and Indian adults in KwaZulu- Natal, South Africa. Clin Biochem 2018; 59: 43-49
13. Ploth DW, Mbwambo JK, Fonner VA et al. Prevalence of CKD, diabetes, and hypertension in rural Tanzania. Kidney Int Rep 2018; 3: 905-915
14. Rangwani N, Facaros S, Wang J et al. Minimal change disease and malaria. Clin Kidney J 2019 (in this issue)
15. McQuarrie EP, Mackinnon B, Bell S et al. Multiple socioeconomic deprivation and impact on survival in patients with primary glomerulonephritis. Clin Kidney J 2017; 10: 49-54
16. Sanchez-Niño MD, Ortiz A. Does wealth make health? Cherchez la renal replacement therapy. Clin Kidney J 2017; 10: 45-48
17. Afsar B, Elsurer Afsar R, Kanbay A et al. Air pollution and kidney disease: Review of current evidence. Clin Kidney J 2019; 12: 19-32